Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
The Indian generic drug maker Sun Pharmaceutical Industries is the latest drug company to receive an inquiry on pricing from U.S. authorities. Sun Pharma says its U.S. subsidiary received a grand jury subpoena from the Department of Justice’s antitrust division seeking information on generic drug pricing and communications with competitors and others on the sale of generics. The probe comes as Congress is pressuring regulators to investigate rising generic drug prices. Other generic drug makers including Dr. Reddy’s Laboratories, Allergan, and Par Pharmaceutical received subpoenas last year.
This article has been sent to the following recipient: